{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:14:49Z","timestamp":1791234889784,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.biopha.2016.02.009","type":"journal-article","created":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T14:01:06Z","timestamp":1457704866000},"page":"241-246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Altered E-NTPDase\/E-ADA activities and CD39 expression in platelets of sickle cell anemia patients"],"prefix":"10.1016","volume":"79","author":[{"given":"L\u00edvia G.","family":"Castilhos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro H.","family":"Doleski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Adefegha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara V.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jader B.","family":"Ruchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela B.R.","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2016.02.009_bib0005","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2016.02.009_bib0010","first-page":"492","article-title":"Pathophysiology and treatment of sickle cell disease","volume":"3","author":"Raphael","year":"2005","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2016.02.009_bib0015","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.1182\/blood-2010-06-290643","article-title":"Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease","volume":"116","author":"Wallace","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2016.02.009_bib0020","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0022-3565(25)21284-8","article-title":"Injured erythrocytes release adenosine deaminase into the circulation","volume":"279","author":"Jackson","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2016.02.009_bib0025","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/nm.2507","article-title":"Ischemia and reperfusion from mechanism to translation","volume":"17","author":"Eltzschig","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2016.02.009_bib0030","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/jcp.33.7.622","article-title":"Platelet hyperactivity in sickle-cell disease: a consequence of hyposplenism","volume":"33","author":"Kenny","year":"1980","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.biopha.2016.02.009_bib0035","first-page":"17","article-title":"Platelet activation during steady state sickle cell disease","volume":"14","author":"Westwick","year":"1983","journal-title":"J. Med."},{"key":"10.1016\/j.biopha.2016.02.009_bib0040","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1365-2141.2012.09218.x","article-title":"Elevated plasma levels and platelet-associated expression of the pro-thrombotic and pro-inflammatory protein TNFSF14 (LIGHT), in sickle cell disease","volume":"158","author":"Garrido","year":"2012","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.biopha.2016.02.009_bib0045","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/01.ATV.0000220374.00602.a2","article-title":"Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation","volume":"26","author":"Lee","year":"2006","journal-title":"Arterioscler. Thromb.Vasc. Biol."},{"key":"10.1016\/j.biopha.2016.02.009_bib0050","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1161\/CIRCULATIONAHA.107.690180","article-title":"CD39\/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia\/reperfusion injury","volume":"116","author":"Kohler","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2016.02.009_bib0055","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1084\/jem.20030891","article-title":"Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors","volume":"198","author":"Eltzschig","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2016.02.009_bib0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-065X.1998.tb01574.x","article-title":"Ecto-enzyme and signaling functions of lymphocyte CD73","volume":"161","author":"Resta","year":"1998","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biopha.2016.02.009_bib0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-065X.1998.tb01569.x","article-title":"Enzymatic and extraenzymatic role of ecto-adenosine deaminase in lymphocytes","volume":"161","author":"Franco","year":"1998","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biopha.2016.02.009_bib0070","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11302-006-9028-9","article-title":"Residual platelet ADP reactivity after clopidogrel treatment is dependent on activation of both the unblocked P2Y1 and the P2Y12 receptor and is correlated with protein expression of P2Y12","volume":"3","author":"Braun","year":"2007","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.biopha.2016.02.009_bib0075","first-page":"411","article-title":"Adenosine diphosphate receptors on blood platelets potential new targets for antiplatelet therapy","volume":"52","author":"Rozalski","year":"2005","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.biopha.2016.02.009_bib0080","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1067\/mlc.2002.126719","article-title":"Role of extracellular ATP metabolism in regulation of platelet reactivity","volume":"140","author":"Birk","year":"2002","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.biopha.2016.02.009_bib0085","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/pr.113.008029","article-title":"Purinergic signaling and blood vessels in health and disease","volume":"66","author":"Burnstock","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biopha.2016.02.009_bib0090","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1111\/j.1538-7836.2003.00479.x","article-title":"Heterologous cell\u2013cell interactions: thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase-1)","volume":"1","author":"Marcus","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.biopha.2016.02.009_bib0095","unstructured":"World Health Organization. [2015.10.02]. Website http:\/\/www.who.int\/classifications\/icd\/en\/."},{"key":"10.1016\/j.biopha.2016.02.009_bib0100","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/09537109609023582","article-title":"ATP diphosphohydrolase activity (Apyrase, EC 3.6.1.5.) in human blood platelets","volume":"7","author":"Pilla","year":"1996","journal-title":"Platelets"},{"key":"10.1016\/j.biopha.2016.02.009_bib0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0049-3848(03)00178-6","article-title":"Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies","volume":"109","author":"Lunkes","year":"2003","journal-title":"Thromb. Res."},{"key":"10.1016\/j.biopha.2016.02.009_bib0110","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.biopha.2016.02.009_bib0115","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0003-2697(86)90640-8","article-title":"A direct colorimetric assay for Ca2+ stimulated ATPase activity","volume":"157","author":"Chan","year":"1986","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.biopha.2016.02.009_bib0120","series-title":"Methods of Enzymatic Analysis","first-page":"315","article-title":"Colorimetric method","author":"Giusti","year":"1984"},{"key":"10.1016\/j.biopha.2016.02.009_bib0125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.biopha.2015.05.011","article-title":"Sickle cell anemia induces changes in peripheral lymphocytes E-NTPDase\/E-ADA activities and cytokines secretion in patients under treatment","volume":"73","author":"Castilhos","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2016.02.009_bib0130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10739680802279394","article-title":"Sickle red cell-endothelium interactions","volume":"16","author":"Kaul","year":"2009","journal-title":"Microcirculation"},{"key":"10.1016\/j.biopha.2016.02.009_bib0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0268-960X(96)90018-1","article-title":"The pathophysiology of vascular obstruction in the sickle syndromes","volume":"10","author":"Kaul","year":"1996","journal-title":"Blood Rev."},{"key":"10.1016\/j.biopha.2016.02.009_bib0140","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/01.moh.0000190108.62414.06","article-title":"Leukocyte adhesion and the pathophysiology of sickle cell disease","volume":"13","author":"Okpala","year":"2006","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.biopha.2016.02.009_bib0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bjh.12336","article-title":"Interplay between coagulation and vascular inflammation in sickle cell disease","volume":"162","author":"Sparkenbaugh","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.biopha.2016.02.009_bib0150","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.redox.2015.07.018","article-title":"Oxidative stress in \u03b2-thalassemia and sickle cell disease","volume":"6","author":"Voskou","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2016.02.009_bib0155","doi-asserted-by":"crossref","first-page":"e40829","DOI":"10.1371\/journal.pone.0040829","article-title":"Increased microparticle CD39 in IPAH","volume":"7","author":"Visovatti","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2016.02.009_bib0160","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1161\/CIRCULATIONAHA.107.690180","article-title":"CD39\/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia\/reperfusion injury","volume":"116","author":"K\u00f6hler","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2016.02.009_bib0165","first-page":"55","article-title":"Thromboregulatory potential of endothelial CD39\/nucleoside triphosphate diphosphohydrolase: modulation of purinergic signaling in platelets","volume":"4","author":"Robson","year":"2000","journal-title":"Emerg. Therap. Targets"},{"key":"10.1016\/j.biopha.2016.02.009_bib0170","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s00277-014-2066-4","article-title":"Hydroxycarbamide modulates components involved in the regulation of adenosine levels in blood cells from sickle-cell anemia patients","volume":"93","author":"Silva-Pinto","year":"2014","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.biopha.2016.02.009_bib0175","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1055\/s-0037-1614868","article-title":"Analysis of CD39\/ATP diphosphohydrolase (ATPDase) expression in endothelial cells, platelets and leukocytes","volume":"82","author":"Koziak","year":"1999","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.biopha.2016.02.009_bib0180","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bcmd.2005.12.025","article-title":"Ectonucleotidases of the CD39\/NTPDase family modulate platelet activation and thrombus formation: potential as therapeutic targets","volume":"36","author":"Atkinson","year":"2006","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.biopha.2016.02.009_bib0185","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2141.2010.08499.x","article-title":"Extracellular Ca2+ modulates ADP-evoked aggregation through altered agonist degradation: implications for conditions used to study P2Y receptor activation","volume":"153","author":"Jones","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.biopha.2016.02.009_bib0190","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11302-012-9309-4","article-title":"Cellular function and molecular structure of ecto-nucleotidases","volume":"8","author":"Zimmermann","year":"2012","journal-title":"Purinergic signal."},{"key":"10.1016\/j.biopha.2016.02.009_bib0195","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1096\/fj.12-205658","article-title":"Metabolism of circulating ADP in the bloodstream is mediated via integrated actions of soluble adenylate kinase-1 and NTPDase1\/CD39 activities","volume":"26","author":"Yegutkin","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2016.02.009_bib0200","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1042\/bj1030773","article-title":"The adenylate kinase of human plasma, erythrocytes and platelets in relation to the degradation of adenosine diphosphate in plasma","volume":"103","author":"Haslam","year":"1967","journal-title":"Biochem. J."},{"key":"10.1016\/j.biopha.2016.02.009_bib0205","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/9783527621095.ch8","article-title":"Integration of adenylate kinase: glycolytic circuits in cellular energetics","volume":"8","author":"Dzeja","year":"2007","journal-title":"Mol. Syst. Bioenerg."},{"key":"10.1016\/j.biopha.2016.02.009_bib0210","doi-asserted-by":"crossref","first-page":"e89012","DOI":"10.1371\/journal.pone.0089012","article-title":"Endothelial activation by platelets from sickle cell anemia patients","volume":"2","author":"Proen\u00e7a-Ferreira","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2016.02.009_bib0215","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/MOH.0b013e32835f55f9","article-title":"New insights into sickle cell disease: a disease of hypoxia","volume":"20","author":"Sun","year":"2013","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.biopha.2016.02.009_bib0220","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nm.2280","article-title":"Detrimental effects of adenosine signaling in sickle cell disease","volume":"17","author":"Zhang","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2016.02.009_bib0225","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1172\/JCI33467","article-title":"Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling","volume":"118","author":"Mi","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2016.02.009_bib0230","doi-asserted-by":"crossref","first-page":"e112741","DOI":"10.1371\/journal.pone.0112741","article-title":"Inhibition of platelet activation and thrombus formation by adenosine and inosine: studies on their relative contribution and molecular modeling","volume":"9","author":"Fuentes","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2016.02.009_bib0235","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1161\/01.ATV.0000174798.25085.d6","article-title":"Protective mechanisms of inosine in platelet activation and cerebral ischemic damage","volume":"25","author":"Hsiao","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216300786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216300786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:01:48Z","timestamp":1760094108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332216300786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":47,"alternative-id":["S0753332216300786"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2016.02.009","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered E-NTPDase\/E-ADA activities and CD39 expression in platelets of sickle cell anemia patients","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2016.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}